Interferon gamma receptor 1
| GO Term |
|---|
| plasma membrane |
| membrane |
| GO Term |
|---|
| type II interferon receptor activity |
| cytokine receptor activity |
| cytokine binding |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 34 | N-linked (GlcNAc...) asparagine | |||
| 79 | N-linked (GlcNAc...) asparagine | |||
| 86 | N-linked (GlcNAc...) asparagine | |||
| 179 | N-linked (GlcNAc...) asparagine | |||
| 240 | N-linked (GlcNAc...) asparagine |
|
||
|
|
| Pathway Name | Organism |
|---|---|
| IFNG signaling activates MAPKs | Homo sapiens |
| Interferon gamma signaling | Homo sapiens |
| Potential therapeutics for SARS | Homo sapiens |
| Regulation of IFNG signaling | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111955 | immunodeficiency 27A | |
| DOID:0111956 | immunodeficiency 27B | |
| DOID:2043 | hepatitis B | |
| DOID:2841 | asthma | |
| DOID:399 | tuberculosis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025